Low-intensity exercise enhances expression of markers of alternative activation in circulating leukocytes: Roles of PPARγ and Th2 cytokines

Atherosclerosis

Volumn 212, Issue 2, 2010, Pages 668-673

  Yakeu, G ^a   Butcher, L ^a   Isa, S ^a   Webb, R ^a   Roberts, A W ^b   Thomas, A W ^a   Backx, K ^a   James, P E ^b   Morris, K ^a  

^a CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Anti atherogenic; Anti inflammatory; Exercise; Monocyte polarisation; PPAR

Indexed keywords

ACYL MALONYL CONDENSING ENZYME 1; BIOLOGICAL MARKER; CD14 ANTIGEN; CITRATE SYNTHASE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; MANNOSE RECEPTOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CELL DIFFERENTIATION; CELL POLARITY; CIRCULATION; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN EXPERIMENT; LEUKOCYTE; LEUKOCYTE ACTIVATION; MACROPHAGE; MALE; MONOCYTE; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITTING; TH1 CELL; TH2 CELL; TREADMILL EXERCISE; WALKING;

ADULT; CELL DIFFERENTIATION; EXERCISE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-10; INTERLEUKIN-4; LEUKOCYTES; MACROPHAGES; MALE; MIDDLE AGED; PHENOTYPE; PPAR GAMMA; TH2 CELLS;

EID: 77957712861     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.07.002     Document Type: Article

References (30)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999, 340:115-126.
2. Glass C.K., Witztum J.L. Atherosclerosis: the road ahead. Cell 2001, 104:503-516.
3. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19(1):71-82.
4. Ancuta P., Liu K.Y., Misra V., Wacleche V.S., Gosselin A., Zhou X., et al. Transcriptional profiling reveals developmental relationship and distinct biological functions of CD16+ and CD16-monocyte subsets. BMC Genomics 2009, 10:403.
5. Woollard K.J., Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 2010, 7(2):77-86.
6. Lumeng C.N., Bodzin J.L., Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007, 117(1):175-184.
7. Porcheray F., Viaud S., Rimianol A.C., Leone C., Samah B., Dereudrde-Bosquet N., et al. Macrophage activation switching an asset for the resolution of inflammation. Clin Exp Immunol 2005, 142:481-489.
8. Gordon S. Macrophage heterogeneity and tissue lipids. J Clin Invest 2007, 117:89-93.
9. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarisation. Trends Immunol 2004, 25:677-686.
10. Bouhlel M.A., Derudas B., Rigamonti E., Dievart R., Brozek J., Haulon S., et al. PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 2007, 6:137-143.
11. Smith S.A. Central role of the adipocyte in the insulin-sensitizing and cardiovascular risk modifying actions of the thiazolidinediones. Biochimie 2003, 85:1219-1230.
12. Fernandez A.Z. Peroxisome proliferator-activated receptors in the modulation of the immune/inflammatory response in atherosclerosis. PPAR Res 2008, 2008:285842.
13. Handschin C., Speigelman B.M. PPARγ coactivators, energy homeostasis and metabolism. Endocrine Rev 2006, 27:728-735.
14. Handschin C., Rhee J., Lin J., Tarr P., Spiegelman B.M. An autoregulatory loop controls PGC-1α expression in muscle. Proc Natl Acad Sci USA 2003, 100:7111-7116.
15. Satoh N., Shimatsu A., Himeno A., Sasaki Y., Yamakage H., Yamada K., et al. Unbalanced M1/M2 phenotype of peripheral blood monocytes in obese diabetic patients: effect of pioglitazone. Diabetes Care 2010, 33(1):e7.
16. Huang J.T., Welch J.S., Ricote M., Binder C.J., Willson T.M., Kelly C., et al. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 1999, 400(6742):378-382.
17. Charo I.F. Macrophage polarization and insulin resistance: PPARγ in control. Cell Metab 2007, 6:96-98.
18. Odegaard J.I., Ricardo-Gonzalez R.R., Goforth M.H., Morel C.R., Subramanian V., Mukundan L., et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007, 447(7148):1116-1120.
19. Akiyama T.E., Sakai S., Lambert G., Nicol C.J., Matsusue K., Pimprale S., et al. Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Mol Cell Biol 2002, 22(8):2607-2619.
20. Butcher L., Thomas A.W., Backx K., Roberts A., Webb R., Morris K. Low-intensity exercise exerts beneficial effects on plasma lipids via PPARγ. Med Sci Sports Exerc 2008, 40(7):1-7.
21. Tontonoz P., Nagy L., Alvarez J.G., Thomazy V.A., Evans R.M. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998, 93(2):241-252.
22. Bouhlel M.A., Brozek J., Derudas B., Zawadzki C., Jude B., Staels B., et al. Unlike PPARγ, PPARα or PPARβ/δ activation does not promote human monocyte differentiation toward alternative macrophages. Biochem Biophys Res Commun 2009, 386:459-462.
23. Odegaard J.I., Ricardo-Gonzalez R.R., Red Eagle A., Vats D., Morel C.R., Goforth M.H., et al. Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab 2008, 7(6):496-507.
24. Bouwens M., Afman L.A., Müller M. Activation of peroxisome proliferator-activated receptor alpha in human peripheral blood mononuclear cells reveals an individual gene expression profile response. BMC Genomics 2008, 2(9):262.
25. Kielian T., Mohsin M.D., Syed S.L., Nirmal K., Phulwani N., Phillips G.W., et al. The synthetic peroxisome proliferator-activated receptor-{gamma} agonist ciglitazone attenuates neuroinflammation and accelerates encapsulation in bacterial brain abscesses. J Immunol 2008, 180:5004-5016.
26. Giraldo E., Garcia J.J., Hinchado M.D., Ortega E. Exercise intensity-dependent changes in the inflammatory response in sedentary women: role of neuroendocrine parameters in the neutrophil phagocytic process and the pro-/anti-inflammatory cytokine balance. Neuroimmunomodulation 2009, 16:237-244.
27. Bruun J.M., Helge J.W., Richelsen B., Stallknecht B. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am J Physiol Endocrinol Metab 2006, 290(5):E961-E967.
28. Febbraio M., Hajjar D.P., Silverstein R.L. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 2001, 108(6):785-791.
29. Ferrer M.D., Tauler P., Sureda A., Tur J.A., Pons A. Antioxidant regulatory mechanisms in neutrophils and lymphocytes after intense exercise. J Sports Sci 2009, 27:49-58.
30. Handschin C., Speigelman B.M. The role of exercise and PGC-1α in inflammation and chronic disease. Nature 2008, 454:463-469.